News & Highlights
- Patient Care
- Research
- Education
- Cancer
- Urologic Subspecialties
This past June the Dept. Urology celebrated the Emil A. Tanagho Visiting Professor and the graduating residents.
Here are some highlights from the event.
- Patient Care
- Research
- Education
- Cancer
- Urologic Subspecialties
- Children
The Department of Urology recently celebrated Drs. Overland, Lindsey and Yang take the next step in their Urologic careers as well-respected 2022 graduates of the UCSF Urology Residency program. Each has made their mark in advancing urologic care and have been – and will continue to be – a beloved part of the UCSF Urology team.
- Patient Care
- Research
- Education
- Cancer
- Urologic Subspecialties
- Children
The UCSF Department of Urology condemns, in the strongest possible terms, the decision by the Supreme Court to allow states to restrict access to safe medical abortion services. Ours is a specialty very much concerned with women’s and reproductive health, and we see governmental intrusions into the physician-patient relationship as our – and everyone’s – issue.
- Patient Care
- Research
- Education
- Cancer
- Urologic Subspecialties
- Children
The 46th Northern California Research Seminar was held virtually on Saturday, May 7, 2022.
- Patient Care
- Education
- Cancer
The Urology Patient Services Committee recently held its 90th quarterly meeting.
- Patient Care
- Research
- Education
- Urologic Subspecialties
Dr. Alan Shindel, professor of clinical urology at UCSF, was announced as the Incoming Chair for the American Urological Association (AUA) Core Curriculum Committee. Dr. Shindel will assume these duties June 1, 2022. He will become Chair of the Committee as of June 1, 2023.
- Patient Care
- Research
- Education
- Urologic Subspecialties
The Haile T. Debas Academy of Medical Educators announced Dr.
Pages
Filter By Topic
Filter by Date
Media Contact
Elizabeth Fernandez
UCSF Department of Urology
San Francisco, CA 94143
[email protected]
415/514-1592
The California Institute for Regenerative Medicine (CIRM) approved investing more than $3.8 million in a Phase 1 clinical trial to create a stem cell-based therapy for urethral stricture disease led by Wake Forest University Health Sciences and UCSF Urology, which will serve as the main clinical site. UCSF Urology is a leading center internationally for the treatment and study of urethral stricture disease (https://expertscape.com/ex/urethral+stricture).